Companies: 10,795·Total market cap: $144.5T
Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

FLGTNASDAQHealthcare● Active
$18.69
$-0.46(-2.40%)
Market Cap$530807644
P/E Ratio
52W High$31.04
52W Low$13.46

Fulgent Genetics, Inc.(FLGT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · FLGT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.32B$0.28B$0.29B$0.62B$0.99B
Cost of Revenue$0.19B$0.18B$0.18B$0.25B$0.22B
Gross Profit$0.13B$0.11B$0.10B$0.37B$0.78B
Gross Margin %(computed)40.56%37.82%36.12%59.28%78.29%
Operating Expenses
R&D Expenses$0.05B$0.05B$0.04B$0.03B$0.02B
G&A Expenses$0.12B$0.09B$0.09B$0.11B$0.05B
Total Operating Expenses$0.22B$0.18B$0.30B$0.19B$0.10B
Operating Income($0.09B)($0.07B)($0.20B)$0.18B$0.68B
Operating Margin %(computed)-28.23%-26.08%-67.61%28.84%68.10%
Interest Income$0.03B$0.03B$0.02B$0.01B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.07B)($0.05B)($0.17B)$0.18B$0.68B
Income Tax Expense($0.01B)($0.01B)$0.00B$0.04B$0.17B
Net Income($0.06B)($0.04B)($0.17B)$0.14B$0.51B
Net Margin %(computed)-18.75%-15.07%-58.03%23.17%51.12%
Per Share & EBITDA
EPS (Basic)$-1.97$-1.41$-5.63$4.76$17.13
Wtd Avg Shares0.03B0.03B0.03B0.03B0.03B
EBITDA($0.05B)($0.05B)($0.15B)$0.22B$0.69B
EBITDA Margin %(computed)-14.20%-17.28%-50.98%35.17%69.21%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Fulgent Genetics, Inc.

关于Fulgent Genetics, Inc.(FLGT)损益表

Fulgent Genetics, Inc.(FLGT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,FLGT实现营收$0.32B,毛利润$0.13B(毛利率40.56%),净利润($0.06B)(净利率-18.75%)。

常见问题

FLGT · 4 问

Fulgent Genetics, Inc.(FLGT)2025财年营收为$0.32B,同比up13.8%。

FLGT revenueFLGT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08